HEADER HYDROLASE 29-JUL-13 4BZS TITLE HUMAN ANGIOTENISN CONVERTING ENZYME N-DOMAIN IN COMPLEX WITH K-26 COMPND MOL_ID: 1; COMPND 2 MOLECULE: ANGIOTENSIN-CONVERTING ENZYME; COMPND 3 CHAIN: A, B; COMPND 4 FRAGMENT: N DOMAIN, RESIDUES 30-657; COMPND 5 SYNONYM: ACE, DIPEPTIDYL CARBOXYPEPTIDASE I, KININASE II, CD143, COMPND 6 ANGIOTENSIN-CONVERTING ENZYME, SOLUBLE FORM; COMPND 7 EC: 3.2.1.-, 3.4.15.1; COMPND 8 ENGINEERED: YES; COMPND 9 MUTATION: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 ORGANISM_TAXID: 9606; SOURCE 5 EXPRESSION_SYSTEM: CRICETULUS GRISEUS; SOURCE 6 EXPRESSION_SYSTEM_COMMON: CHINESE HAMSTER; SOURCE 7 EXPRESSION_SYSTEM_TAXID: 10029; SOURCE 8 EXPRESSION_SYSTEM_CELL_LINE: OVARY CELLS KEYWDS HYDROLASE, ZINC METALLOPEPTIDASE, ANTIHYPERTENSIVE AGENT EXPDTA X-RAY DIFFRACTION AUTHOR G.J.KRAMER,A.MOHD,S.L.U.SCHWAGER,G.MASUYER,K.R.ACHARYA,E.D.STURROCK, AUTHOR 2 B.O.BACHMANN REVDAT 6 13-NOV-24 4BZS 1 REMARK REVDAT 5 20-DEC-23 4BZS 1 REMARK HETSYN REVDAT 4 29-JUL-20 4BZS 1 COMPND REMARK HETNAM LINK REVDAT 4 2 1 SITE ATOM REVDAT 3 07-FEB-18 4BZS 1 AUTHOR REMARK REVDAT 2 18-JUN-14 4BZS 1 JRNL REVDAT 1 26-FEB-14 4BZS 0 JRNL AUTH G.J.KRAMER,A.MOHD,S.L.U.SCHWAGER,G.MASUYER,K.R.ACHARYA, JRNL AUTH 2 E.D.STURROCK,B.O.BACHMANN JRNL TITL INTERKINGDOM PHARMACOLOGY OF ANGIOTENSIN-I CONVERTING ENZYME JRNL TITL 2 INHIBITOR PHOSPHONATES PRODUCED BY ACTINOMYCETES JRNL REF ACS MED.CHEM.LETT. V. 5 346 2014 JRNL REFN ISSN 1948-5875 JRNL PMID 24900839 JRNL DOI 10.1021/ML4004588 REMARK 2 REMARK 2 RESOLUTION. 2.10 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : REFMAC 5.7.0029 REMARK 3 AUTHORS : MURSHUDOV,SKUBAK,LEBEDEV,PANNU,STEINER, REMARK 3 : NICHOLLS,WINN,LONG,VAGIN REMARK 3 REMARK 3 REFINEMENT TARGET : MAXIMUM LIKELIHOOD REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 2.10 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 36.61 REMARK 3 DATA CUTOFF (SIGMA(F)) : NULL REMARK 3 COMPLETENESS FOR RANGE (%) : 83.5 REMARK 3 NUMBER OF REFLECTIONS : 72571 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : THROUGHOUT REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM REMARK 3 R VALUE (WORKING + TEST SET) : 0.235 REMARK 3 R VALUE (WORKING SET) : 0.233 REMARK 3 FREE R VALUE : 0.277 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 5.000 REMARK 3 FREE R VALUE TEST SET COUNT : 3841 REMARK 3 REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN. REMARK 3 TOTAL NUMBER OF BINS USED : 20 REMARK 3 BIN RESOLUTION RANGE HIGH (A) : 2.10 REMARK 3 BIN RESOLUTION RANGE LOW (A) : 2.15 REMARK 3 REFLECTION IN BIN (WORKING SET) : 4131 REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : 63.76 REMARK 3 BIN R VALUE (WORKING SET) : 0.3780 REMARK 3 BIN FREE R VALUE SET COUNT : 215 REMARK 3 BIN FREE R VALUE : 0.4080 REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 9941 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 345 REMARK 3 SOLVENT ATOMS : 161 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : NULL REMARK 3 MEAN B VALUE (OVERALL, A**2) : 40.64 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : 0.65000 REMARK 3 B22 (A**2) : -0.38000 REMARK 3 B33 (A**2) : 1.08000 REMARK 3 B12 (A**2) : 2.04000 REMARK 3 B13 (A**2) : 1.95000 REMARK 3 B23 (A**2) : -1.36000 REMARK 3 REMARK 3 ESTIMATED OVERALL COORDINATE ERROR. REMARK 3 ESU BASED ON R VALUE (A): 0.307 REMARK 3 ESU BASED ON FREE R VALUE (A): 0.238 REMARK 3 ESU BASED ON MAXIMUM LIKELIHOOD (A): 0.192 REMARK 3 ESU FOR B VALUES BASED ON MAXIMUM LIKELIHOOD (A**2): 7.674 REMARK 3 REMARK 3 CORRELATION COEFFICIENTS. REMARK 3 CORRELATION COEFFICIENT FO-FC : 0.943 REMARK 3 CORRELATION COEFFICIENT FO-FC FREE : 0.919 REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES COUNT RMS WEIGHT REMARK 3 BOND LENGTHS REFINED ATOMS (A): 10605 ; 0.005 ; 0.019 REMARK 3 BOND LENGTHS OTHERS (A): 9635 ; 0.001 ; 0.020 REMARK 3 BOND ANGLES REFINED ATOMS (DEGREES): 14446 ; 0.914 ; 1.966 REMARK 3 BOND ANGLES OTHERS (DEGREES): 22070 ; 0.748 ; 3.003 REMARK 3 TORSION ANGLES, PERIOD 1 (DEGREES): 1220 ; 4.922 ; 5.000 REMARK 3 TORSION ANGLES, PERIOD 2 (DEGREES): 528 ;34.530 ;23.826 REMARK 3 TORSION ANGLES, PERIOD 3 (DEGREES): 1593 ;13.735 ;15.000 REMARK 3 TORSION ANGLES, PERIOD 4 (DEGREES): 64 ;15.393 ;15.000 REMARK 3 CHIRAL-CENTER RESTRAINTS (A**3): 1515 ; 0.054 ; 0.200 REMARK 3 GENERAL PLANES REFINED ATOMS (A): 11940 ; 0.003 ; 0.021 REMARK 3 GENERAL PLANES OTHERS (A): 2620 ; 0.001 ; 0.020 REMARK 3 NON-BONDED CONTACTS REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED CONTACTS OTHERS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED TORSION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED TORSION OTHERS (A): NULL ; NULL ; NULL REMARK 3 H-BOND (X...Y) REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 H-BOND (X...Y) OTHERS (A): NULL ; NULL ; NULL REMARK 3 POTENTIAL METAL-ION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 POTENTIAL METAL-ION OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY VDW REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY VDW OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY H-BOND REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY H-BOND OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY METAL-ION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY METAL-ION OTHERS (A): NULL ; NULL ; NULL REMARK 3 REMARK 3 ISOTROPIC THERMAL FACTOR RESTRAINTS. COUNT RMS WEIGHT REMARK 3 MAIN-CHAIN BOND REFINED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 MAIN-CHAIN BOND OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 MAIN-CHAIN ANGLE REFINED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 MAIN-CHAIN ANGLE OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SIDE-CHAIN BOND REFINED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SIDE-CHAIN BOND OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SIDE-CHAIN ANGLE REFINED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SIDE-CHAIN ANGLE OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 LONG RANGE B REFINED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 LONG RANGE B OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 REMARK 3 ANISOTROPIC THERMAL FACTOR RESTRAINTS. COUNT RMS WEIGHT REMARK 3 RIGID-BOND RESTRAINTS (A**2): NULL ; NULL ; NULL REMARK 3 SPHERICITY; FREE ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SPHERICITY; BONDED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 REMARK 3 NCS RESTRAINTS STATISTICS REMARK 3 NUMBER OF DIFFERENT NCS GROUPS : NULL REMARK 3 REMARK 3 TLS DETAILS REMARK 3 NUMBER OF TLS GROUPS : NULL REMARK 3 REMARK 3 BULK SOLVENT MODELLING. REMARK 3 METHOD USED : MASK REMARK 3 PARAMETERS FOR MASK CALCULATION REMARK 3 VDW PROBE RADIUS : 1.20 REMARK 3 ION PROBE RADIUS : 0.80 REMARK 3 SHRINKAGE RADIUS : 0.80 REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: HYDROGENS HAVE BEEN ADDED IN THE RIDING REMARK 3 POSITIONS. REMARK 4 REMARK 4 4BZS COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY PDBE ON 29-JUL-13. REMARK 100 THE DEPOSITION ID IS D_1290057845. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 09-AUG-10 REMARK 200 TEMPERATURE (KELVIN) : 100 REMARK 200 PH : 8.5 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : DIAMOND REMARK 200 BEAMLINE : I03 REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 1.282 REMARK 200 MONOCHROMATOR : NULL REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : CCD REMARK 200 DETECTOR MANUFACTURER : ADSC QUANTUM 315 REMARK 200 INTENSITY-INTEGRATION SOFTWARE : HKL-2000 REMARK 200 DATA SCALING SOFTWARE : SCALEPACK REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 90926 REMARK 200 RESOLUTION RANGE HIGH (A) : 2.100 REMARK 200 RESOLUTION RANGE LOW (A) : 74.000 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : 0.000 REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 84.0 REMARK 200 DATA REDUNDANCY : 1.800 REMARK 200 R MERGE (I) : 0.08000 REMARK 200 R SYM (I) : NULL REMARK 200 FOR THE DATA SET : 7.8000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 2.10 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 2.18 REMARK 200 COMPLETENESS FOR SHELL (%) : 71.0 REMARK 200 DATA REDUNDANCY IN SHELL : 1.50 REMARK 200 R MERGE FOR SHELL (I) : 0.49000 REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 FOR SHELL : 1.600 REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: PHASER REMARK 200 STARTING MODEL: PDB ENTRY 3NXQ REMARK 200 REMARK 200 REMARK: NONE REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 56.00 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.80 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: MORPHEUS A9 (0.06M DIVALENTS, 0.1M REMARK 280 TRIS/BICINE PH 8.5, 30% PEG550MME/PEG20K) SILVER BULLET G3 REMARK 280 SOLUTION (HAMPTON RESEARCH) ADDITIVE. 1:1:1 PROTEIN:RESERVOIR: REMARK 280 ADDITIVE REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 1 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1, 2 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: MONOMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 APPLY THE FOLLOWING TO CHAINS: A, C, D, E REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 350 REMARK 350 BIOMOLECULE: 2 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: MONOMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 APPLY THE FOLLOWING TO CHAINS: B, F, G, H REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 LEU A 613 REMARK 465 VAL A 614 REMARK 465 THR A 615 REMARK 465 ASP A 616 REMARK 465 GLU A 617 REMARK 465 ALA A 618 REMARK 465 GLU A 619 REMARK 465 ALA A 620 REMARK 465 SER A 621 REMARK 465 LYS A 622 REMARK 465 PHE A 623 REMARK 465 VAL A 624 REMARK 465 GLU A 625 REMARK 465 GLU A 626 REMARK 465 TYR A 627 REMARK 465 ASP A 628 REMARK 465 LEU A 629 REMARK 465 ILE B 611 REMARK 465 ASP B 612 REMARK 465 LEU B 613 REMARK 465 VAL B 614 REMARK 465 THR B 615 REMARK 465 ASP B 616 REMARK 465 GLU B 617 REMARK 465 ALA B 618 REMARK 465 GLU B 619 REMARK 465 ALA B 620 REMARK 465 SER B 621 REMARK 465 LYS B 622 REMARK 465 PHE B 623 REMARK 465 VAL B 624 REMARK 465 GLU B 625 REMARK 465 GLU B 626 REMARK 465 TYR B 627 REMARK 465 ASP B 628 REMARK 465 LEU B 629 REMARK 470 REMARK 470 MISSING ATOM REMARK 470 THE FOLLOWING RESIDUES HAVE MISSING ATOMS (M=MODEL NUMBER; REMARK 470 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE NUMBER; REMARK 470 I=INSERTION CODE): REMARK 470 M RES CSSEQI ATOMS REMARK 470 GLU A 403 CG CD OE1 OE2 REMARK 470 GLU A 609 CG CD OE1 OE2 REMARK 470 GLU B 403 CG CD OE1 OE2 REMARK 470 ASP B 412 CG OD1 OD2 REMARK 470 GLU B 609 CG CD OE1 OE2 REMARK 480 REMARK 480 ZERO OCCUPANCY ATOM REMARK 480 THE FOLLOWING RESIDUES HAVE ATOMS MODELED WITH ZERO REMARK 480 OCCUPANCY. THE LOCATION AND PROPERTIES OF THESE ATOMS REMARK 480 MAY NOT BE RELIABLE. (M=MODEL NUMBER; RES=RESIDUE NAME; REMARK 480 C=CHAIN IDENTIFIER; SSEQ=SEQUENCE NUMBER; I=INSERTION CODE): REMARK 480 M RES C SSEQI ATOMS REMARK 480 ILE A 92 CD1 REMARK 480 LYS A 126 CD CE NZ REMARK 480 ILE B 92 CD1 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: CLOSE CONTACTS IN SAME ASYMMETRIC UNIT REMARK 500 REMARK 500 THE FOLLOWING ATOMS ARE IN CLOSE CONTACT. REMARK 500 REMARK 500 ATM1 RES C SSEQI ATM2 RES C SSEQI DISTANCE REMARK 500 OE1 GLU B 522 C3 BMA H 3 1.43 REMARK 500 OE1 GLU B 522 O3 BMA H 3 1.85 REMARK 500 NE2 GLN A 598 O HOH A 2064 2.19 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: COVALENT BOND LENGTHS REMARK 500 REMARK 500 THE STEREOCHEMICAL PARAMETERS OF THE FOLLOWING RESIDUES REMARK 500 HAVE VALUES WHICH DEVIATE FROM EXPECTED VALUES BY MORE REMARK 500 THAN 6*RMSD (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 500 IDENTIFIER; SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT: (10X,I3,1X,2(A3,1X,A1,I4,A1,1X,A4,3X),1X,F6.3) REMARK 500 REMARK 500 EXPECTED VALUES PROTEIN: ENGH AND HUBER, 1999 REMARK 500 EXPECTED VALUES NUCLEIC ACID: CLOWNEY ET AL 1996 REMARK 500 REMARK 500 M RES CSSEQI ATM1 RES CSSEQI ATM2 DEVIATION REMARK 500 LYS A 126 CG LYS A 126 CD -0.219 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 ASN A 45 80.71 -166.26 REMARK 500 GLN A 81 -22.51 88.84 REMARK 500 THR A 133 78.34 -69.54 REMARK 500 ALA A 134 -64.41 -130.45 REMARK 500 ASN A 203 59.08 36.55 REMARK 500 PRO A 272 -178.67 -68.77 REMARK 500 ASP A 273 -23.86 78.76 REMARK 500 LYS A 341 -54.36 -155.60 REMARK 500 ASN B 45 78.08 -166.51 REMARK 500 LEU B 75 -60.92 -93.20 REMARK 500 TYR B 76 47.48 -101.97 REMARK 500 GLN B 81 -9.11 99.22 REMARK 500 THR B 135 130.35 69.69 REMARK 500 ASN B 203 54.58 38.62 REMARK 500 LYS B 341 -53.50 -133.56 REMARK 500 GLU B 609 -164.23 -77.43 REMARK 500 REMARK 500 REMARK: NULL REMARK 600 REMARK 600 HETEROGEN REMARK 600 REMARK 600 9X6 CORRESPONDS TO THIODIGLYCOLIC ACID PRESENT IN THE SILVER REMARK 600 BULLET G3 SOLUTION (HAMPTON RESEARCH) REMARK 610 REMARK 610 MISSING HETEROATOM REMARK 610 THE FOLLOWING RESIDUES HAVE MISSING ATOMS (M=MODEL NUMBER; REMARK 610 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE NUMBER; REMARK 610 I=INSERTION CODE): REMARK 610 M RES C SSEQI REMARK 610 PE4 A 703 REMARK 610 PG4 B 1611 REMARK 620 REMARK 620 METAL COORDINATION REMARK 620 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 620 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE): REMARK 620 REMARK 620 COORDINATION ANGLES FOR: M RES CSSEQI METAL REMARK 620 ZN A 701 ZN REMARK 620 N RES CSSEQI ATOM REMARK 620 1 HIS A 361 NE2 REMARK 620 2 HIS A 365 NE2 100.6 REMARK 620 3 GLU A 389 OE1 111.2 112.3 REMARK 620 4 K26 A1001 OAG 87.2 78.7 155.2 REMARK 620 5 K26 A1001 OAK 119.2 120.9 92.8 63.0 REMARK 620 N 1 2 3 4 REMARK 620 REMARK 620 COORDINATION ANGLES FOR: M RES CSSEQI METAL REMARK 620 ZN B 701 ZN REMARK 620 N RES CSSEQI ATOM REMARK 620 1 HIS B 361 NE2 REMARK 620 2 HIS B 365 NE2 103.0 REMARK 620 3 GLU B 389 OE1 86.5 96.4 REMARK 620 4 K26 B1001 PBK 99.8 121.5 138.3 REMARK 620 5 K26 B1001 OAK 108.9 142.6 104.4 34.6 REMARK 620 6 K26 B1001 OAG 91.4 91.7 171.9 34.5 68.9 REMARK 620 N 1 2 3 4 5 REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: 4BZR RELATED DB: PDB REMARK 900 HUMAN TESTIS ANGIOTENSIN CONVERTING ENZYME IN COMPLEX WITH K-26 REMARK 999 REMARK 999 SEQUENCE REMARK 999 ENGINEERED GLYCOSYLATION MUTANT DBREF 4BZS A 1 628 UNP P12821 ACE_HUMAN 30 657 DBREF 4BZS B 1 628 UNP P12821 ACE_HUMAN 30 657 SEQADV 4BZS LEU A 629 UNP P12821 EXPRESSION TAG SEQADV 4BZS LEU A 576 UNP P12821 PRO 605 ENGINEERED MUTATION SEQADV 4BZS LEU B 629 UNP P12821 EXPRESSION TAG SEQADV 4BZS LEU B 576 UNP P12821 PRO 605 ENGINEERED MUTATION SEQRES 1 A 629 LEU ASP PRO GLY LEU GLN PRO GLY ASN PHE SER ALA ASP SEQRES 2 A 629 GLU ALA GLY ALA GLN LEU PHE ALA GLN SER TYR ASN SER SEQRES 3 A 629 SER ALA GLU GLN VAL LEU PHE GLN SER VAL ALA ALA SER SEQRES 4 A 629 TRP ALA HIS ASP THR ASN ILE THR ALA GLU ASN ALA ARG SEQRES 5 A 629 ARG GLN GLU GLU ALA ALA LEU LEU SER GLN GLU PHE ALA SEQRES 6 A 629 GLU ALA TRP GLY GLN LYS ALA LYS GLU LEU TYR GLU PRO SEQRES 7 A 629 ILE TRP GLN ASN PHE THR ASP PRO GLN LEU ARG ARG ILE SEQRES 8 A 629 ILE GLY ALA VAL ARG THR LEU GLY SER ALA ASN LEU PRO SEQRES 9 A 629 LEU ALA LYS ARG GLN GLN TYR ASN ALA LEU LEU SER ASN SEQRES 10 A 629 MET SER ARG ILE TYR SER THR ALA LYS VAL CYS LEU PRO SEQRES 11 A 629 ASN LYS THR ALA THR CYS TRP SER LEU ASP PRO ASP LEU SEQRES 12 A 629 THR ASN ILE LEU ALA SER SER ARG SER TYR ALA MET LEU SEQRES 13 A 629 LEU PHE ALA TRP GLU GLY TRP HIS ASN ALA ALA GLY ILE SEQRES 14 A 629 PRO LEU LYS PRO LEU TYR GLU ASP PHE THR ALA LEU SER SEQRES 15 A 629 ASN GLU ALA TYR LYS GLN ASP GLY PHE THR ASP THR GLY SEQRES 16 A 629 ALA TYR TRP ARG SER TRP TYR ASN SER PRO THR PHE GLU SEQRES 17 A 629 ASP ASP LEU GLU HIS LEU TYR GLN GLN LEU GLU PRO LEU SEQRES 18 A 629 TYR LEU ASN LEU HIS ALA PHE VAL ARG ARG ALA LEU HIS SEQRES 19 A 629 ARG ARG TYR GLY ASP ARG TYR ILE ASN LEU ARG GLY PRO SEQRES 20 A 629 ILE PRO ALA HIS LEU LEU GLY ASP MET TRP ALA GLN SER SEQRES 21 A 629 TRP GLU ASN ILE TYR ASP MET VAL VAL PRO PHE PRO ASP SEQRES 22 A 629 LYS PRO ASN LEU ASP VAL THR SER THR MET LEU GLN GLN SEQRES 23 A 629 GLY TRP ASN ALA THR HIS MET PHE ARG VAL ALA GLU GLU SEQRES 24 A 629 PHE PHE THR SER LEU GLU LEU SER PRO MET PRO PRO GLU SEQRES 25 A 629 PHE TRP GLU GLY SER MET LEU GLU LYS PRO ALA ASP GLY SEQRES 26 A 629 ARG GLU VAL VAL CYS HIS ALA SER ALA TRP ASP PHE TYR SEQRES 27 A 629 ASN ARG LYS ASP PHE ARG ILE LYS GLN CYS THR ARG VAL SEQRES 28 A 629 THR MET ASP GLN LEU SER THR VAL HIS HIS GLU MET GLY SEQRES 29 A 629 HIS ILE GLN TYR TYR LEU GLN TYR LYS ASP LEU PRO VAL SEQRES 30 A 629 SER LEU ARG ARG GLY ALA ASN PRO GLY PHE HIS GLU ALA SEQRES 31 A 629 ILE GLY ASP VAL LEU ALA LEU SER VAL SER THR PRO GLU SEQRES 32 A 629 HIS LEU HIS LYS ILE GLY LEU LEU ASP ARG VAL THR ASN SEQRES 33 A 629 ASP THR GLU SER ASP ILE ASN TYR LEU LEU LYS MET ALA SEQRES 34 A 629 LEU GLU LYS ILE ALA PHE LEU PRO PHE GLY TYR LEU VAL SEQRES 35 A 629 ASP GLN TRP ARG TRP GLY VAL PHE SER GLY ARG THR PRO SEQRES 36 A 629 PRO SER ARG TYR ASN PHE ASP TRP TRP TYR LEU ARG THR SEQRES 37 A 629 LYS TYR GLN GLY ILE CYS PRO PRO VAL THR ARG ASN GLU SEQRES 38 A 629 THR HIS PHE ASP ALA GLY ALA LYS PHE HIS VAL PRO ASN SEQRES 39 A 629 VAL THR PRO TYR ILE ARG TYR PHE VAL SER PHE VAL LEU SEQRES 40 A 629 GLN PHE GLN PHE HIS GLU ALA LEU CYS LYS GLU ALA GLY SEQRES 41 A 629 TYR GLU GLY PRO LEU HIS GLN CYS ASP ILE TYR ARG SER SEQRES 42 A 629 THR LYS ALA GLY ALA LYS LEU ARG LYS VAL LEU GLN ALA SEQRES 43 A 629 GLY SER SER ARG PRO TRP GLN GLU VAL LEU LYS ASP MET SEQRES 44 A 629 VAL GLY LEU ASP ALA LEU ASP ALA GLN PRO LEU LEU LYS SEQRES 45 A 629 TYR PHE GLN LEU VAL THR GLN TRP LEU GLN GLU GLN ASN SEQRES 46 A 629 GLN GLN ASN GLY GLU VAL LEU GLY TRP PRO GLU TYR GLN SEQRES 47 A 629 TRP HIS PRO PRO LEU PRO ASP ASN TYR PRO GLU GLY ILE SEQRES 48 A 629 ASP LEU VAL THR ASP GLU ALA GLU ALA SER LYS PHE VAL SEQRES 49 A 629 GLU GLU TYR ASP LEU SEQRES 1 B 629 LEU ASP PRO GLY LEU GLN PRO GLY ASN PHE SER ALA ASP SEQRES 2 B 629 GLU ALA GLY ALA GLN LEU PHE ALA GLN SER TYR ASN SER SEQRES 3 B 629 SER ALA GLU GLN VAL LEU PHE GLN SER VAL ALA ALA SER SEQRES 4 B 629 TRP ALA HIS ASP THR ASN ILE THR ALA GLU ASN ALA ARG SEQRES 5 B 629 ARG GLN GLU GLU ALA ALA LEU LEU SER GLN GLU PHE ALA SEQRES 6 B 629 GLU ALA TRP GLY GLN LYS ALA LYS GLU LEU TYR GLU PRO SEQRES 7 B 629 ILE TRP GLN ASN PHE THR ASP PRO GLN LEU ARG ARG ILE SEQRES 8 B 629 ILE GLY ALA VAL ARG THR LEU GLY SER ALA ASN LEU PRO SEQRES 9 B 629 LEU ALA LYS ARG GLN GLN TYR ASN ALA LEU LEU SER ASN SEQRES 10 B 629 MET SER ARG ILE TYR SER THR ALA LYS VAL CYS LEU PRO SEQRES 11 B 629 ASN LYS THR ALA THR CYS TRP SER LEU ASP PRO ASP LEU SEQRES 12 B 629 THR ASN ILE LEU ALA SER SER ARG SER TYR ALA MET LEU SEQRES 13 B 629 LEU PHE ALA TRP GLU GLY TRP HIS ASN ALA ALA GLY ILE SEQRES 14 B 629 PRO LEU LYS PRO LEU TYR GLU ASP PHE THR ALA LEU SER SEQRES 15 B 629 ASN GLU ALA TYR LYS GLN ASP GLY PHE THR ASP THR GLY SEQRES 16 B 629 ALA TYR TRP ARG SER TRP TYR ASN SER PRO THR PHE GLU SEQRES 17 B 629 ASP ASP LEU GLU HIS LEU TYR GLN GLN LEU GLU PRO LEU SEQRES 18 B 629 TYR LEU ASN LEU HIS ALA PHE VAL ARG ARG ALA LEU HIS SEQRES 19 B 629 ARG ARG TYR GLY ASP ARG TYR ILE ASN LEU ARG GLY PRO SEQRES 20 B 629 ILE PRO ALA HIS LEU LEU GLY ASP MET TRP ALA GLN SER SEQRES 21 B 629 TRP GLU ASN ILE TYR ASP MET VAL VAL PRO PHE PRO ASP SEQRES 22 B 629 LYS PRO ASN LEU ASP VAL THR SER THR MET LEU GLN GLN SEQRES 23 B 629 GLY TRP ASN ALA THR HIS MET PHE ARG VAL ALA GLU GLU SEQRES 24 B 629 PHE PHE THR SER LEU GLU LEU SER PRO MET PRO PRO GLU SEQRES 25 B 629 PHE TRP GLU GLY SER MET LEU GLU LYS PRO ALA ASP GLY SEQRES 26 B 629 ARG GLU VAL VAL CYS HIS ALA SER ALA TRP ASP PHE TYR SEQRES 27 B 629 ASN ARG LYS ASP PHE ARG ILE LYS GLN CYS THR ARG VAL SEQRES 28 B 629 THR MET ASP GLN LEU SER THR VAL HIS HIS GLU MET GLY SEQRES 29 B 629 HIS ILE GLN TYR TYR LEU GLN TYR LYS ASP LEU PRO VAL SEQRES 30 B 629 SER LEU ARG ARG GLY ALA ASN PRO GLY PHE HIS GLU ALA SEQRES 31 B 629 ILE GLY ASP VAL LEU ALA LEU SER VAL SER THR PRO GLU SEQRES 32 B 629 HIS LEU HIS LYS ILE GLY LEU LEU ASP ARG VAL THR ASN SEQRES 33 B 629 ASP THR GLU SER ASP ILE ASN TYR LEU LEU LYS MET ALA SEQRES 34 B 629 LEU GLU LYS ILE ALA PHE LEU PRO PHE GLY TYR LEU VAL SEQRES 35 B 629 ASP GLN TRP ARG TRP GLY VAL PHE SER GLY ARG THR PRO SEQRES 36 B 629 PRO SER ARG TYR ASN PHE ASP TRP TRP TYR LEU ARG THR SEQRES 37 B 629 LYS TYR GLN GLY ILE CYS PRO PRO VAL THR ARG ASN GLU SEQRES 38 B 629 THR HIS PHE ASP ALA GLY ALA LYS PHE HIS VAL PRO ASN SEQRES 39 B 629 VAL THR PRO TYR ILE ARG TYR PHE VAL SER PHE VAL LEU SEQRES 40 B 629 GLN PHE GLN PHE HIS GLU ALA LEU CYS LYS GLU ALA GLY SEQRES 41 B 629 TYR GLU GLY PRO LEU HIS GLN CYS ASP ILE TYR ARG SER SEQRES 42 B 629 THR LYS ALA GLY ALA LYS LEU ARG LYS VAL LEU GLN ALA SEQRES 43 B 629 GLY SER SER ARG PRO TRP GLN GLU VAL LEU LYS ASP MET SEQRES 44 B 629 VAL GLY LEU ASP ALA LEU ASP ALA GLN PRO LEU LEU LYS SEQRES 45 B 629 TYR PHE GLN LEU VAL THR GLN TRP LEU GLN GLU GLN ASN SEQRES 46 B 629 GLN GLN ASN GLY GLU VAL LEU GLY TRP PRO GLU TYR GLN SEQRES 47 B 629 TRP HIS PRO PRO LEU PRO ASP ASN TYR PRO GLU GLY ILE SEQRES 48 B 629 ASP LEU VAL THR ASP GLU ALA GLU ALA SER LYS PHE VAL SEQRES 49 B 629 GLU GLU TYR ASP LEU MODRES 4BZS ASN A 45 ASN GLYCOSYLATION SITE MODRES 4BZS ASN A 416 ASN GLYCOSYLATION SITE MODRES 4BZS ASN A 480 ASN GLYCOSYLATION SITE MODRES 4BZS ASN B 45 ASN GLYCOSYLATION SITE MODRES 4BZS ASN B 416 ASN GLYCOSYLATION SITE MODRES 4BZS ASN B 480 ASN GLYCOSYLATION SITE HET NAG C 1 14 HET FUC C 2 10 HET NAG D 1 14 HET NAG D 2 14 HET NAG E 1 14 HET NAG E 2 14 HET BMA E 3 11 HET NAG F 1 14 HET FUC F 2 10 HET NAG G 1 14 HET NAG G 2 14 HET NAG H 1 14 HET NAG H 2 14 HET BMA H 3 11 HET ZN A 701 1 HET CL A 702 1 HET PE4 A 703 13 HET P6G A 704 19 HET PEG A 705 7 HET K26 A1001 37 HET 9X6 A1613 9 HET ZN B 701 1 HET CL B 702 1 HET PEG B 703 7 HET PEG B 704 7 HET PEG B 705 7 HET K26 B1001 37 HET PG4 B1611 7 HET 9X6 B1612 9 HETNAM NAG 2-ACETAMIDO-2-DEOXY-BETA-D-GLUCOPYRANOSE HETNAM FUC ALPHA-L-FUCOPYRANOSE HETNAM BMA BETA-D-MANNOPYRANOSE HETNAM ZN ZINC ION HETNAM CL CHLORIDE ION HETNAM PE4 2-{2-[2-(2-{2-[2-(2-ETHOXY-ETHOXY)-ETHOXY]-ETHOXY}- HETNAM 2 PE4 ETHOXY)-ETHOXY]-ETHOXY}-ETHANOL HETNAM P6G HEXAETHYLENE GLYCOL HETNAM PEG DI(HYDROXYETHYL)ETHER HETNAM K26 N-ACETYL-L-ILE-L-TYR-(R)-1-AMINO-2-(4-HYDROXYPHENYL) HETNAM 2 K26 ETHYLPHOSPHONIC ACID HETNAM 9X6 THIODIGLYCOLIC ACID HETNAM PG4 TETRAETHYLENE GLYCOL HETSYN NAG N-ACETYL-BETA-D-GLUCOSAMINE; 2-ACETAMIDO-2-DEOXY-BETA- HETSYN 2 NAG D-GLUCOSE; 2-ACETAMIDO-2-DEOXY-D-GLUCOSE; 2-ACETAMIDO- HETSYN 3 NAG 2-DEOXY-GLUCOSE; N-ACETYL-D-GLUCOSAMINE HETSYN FUC ALPHA-L-FUCOSE; 6-DEOXY-ALPHA-L-GALACTOPYRANOSE; L- HETSYN 2 FUC FUCOSE; FUCOSE HETSYN BMA BETA-D-MANNOSE; D-MANNOSE; MANNOSE HETSYN PE4 POLYETHYLENE GLYCOL PEG4000 HETSYN P6G POLYETHYLENE GLYCOL PEG400 HETSYN 9X6 2-(2-HYDROXY-2-OXOETHYLSULFANYL)ETHANOIC ACID FORMUL 3 NAG 10(C8 H15 N O6) FORMUL 3 FUC 2(C6 H12 O5) FORMUL 5 BMA 2(C6 H12 O6) FORMUL 9 ZN 2(ZN 2+) FORMUL 10 CL 2(CL 1-) FORMUL 11 PE4 C16 H34 O8 FORMUL 12 P6G C12 H26 O7 FORMUL 13 PEG 4(C4 H10 O3) FORMUL 14 K26 2(C25 H34 N3 O8 P) FORMUL 15 9X6 2(C4 H6 O4 S) FORMUL 22 PG4 C8 H18 O5 FORMUL 24 HOH *161(H2 O) HELIX 1 1 ASP A 2 GLN A 6 5 5 HELIX 2 2 ASP A 13 THR A 44 1 32 HELIX 3 3 THR A 47 GLU A 77 1 31 HELIX 4 4 ASP A 85 THR A 97 1 13 HELIX 5 5 LEU A 98 LEU A 103 5 6 HELIX 6 6 PRO A 104 ALA A 125 1 22 HELIX 7 7 PRO A 141 SER A 150 1 10 HELIX 8 8 SER A 152 GLN A 188 1 37 HELIX 9 9 ASP A 193 SER A 200 1 8 HELIX 10 10 TRP A 201 ASN A 203 5 3 HELIX 11 11 THR A 206 GLY A 238 1 33 HELIX 12 12 TRP A 261 ASN A 263 5 3 HELIX 13 13 ILE A 264 VAL A 269 1 6 HELIX 14 14 VAL A 279 GLY A 287 1 9 HELIX 15 15 ASN A 289 LEU A 304 1 16 HELIX 16 16 PRO A 310 SER A 317 1 8 HELIX 17 17 THR A 352 LYS A 373 1 22 HELIX 18 18 PRO A 376 ARG A 380 5 5 HELIX 19 19 ASN A 384 ILE A 408 1 25 HELIX 20 20 ASP A 417 ILE A 433 1 17 HELIX 21 21 PHE A 435 SER A 451 1 17 HELIX 22 22 PRO A 455 SER A 457 5 3 HELIX 23 23 ARG A 458 GLY A 472 1 15 HELIX 24 24 PHE A 484 LYS A 489 5 6 HELIX 25 25 TYR A 498 ALA A 519 1 22 HELIX 26 26 PRO A 524 CYS A 528 5 5 HELIX 27 27 SER A 533 GLY A 547 1 15 HELIX 28 28 PRO A 551 GLY A 561 1 11 HELIX 29 29 ALA A 567 ASN A 588 1 22 HELIX 30 30 ASP B 2 GLN B 6 5 5 HELIX 31 31 ASP B 13 THR B 44 1 32 HELIX 32 32 THR B 47 TYR B 76 1 30 HELIX 33 33 ASP B 85 ARG B 96 1 12 HELIX 34 34 LEU B 98 LEU B 103 5 6 HELIX 35 35 PRO B 104 ALA B 125 1 22 HELIX 36 36 PRO B 141 SER B 150 1 10 HELIX 37 37 SER B 152 GLN B 188 1 37 HELIX 38 38 ASP B 193 SER B 200 1 8 HELIX 39 39 TRP B 201 ASN B 203 5 3 HELIX 40 40 THR B 206 GLY B 238 1 33 HELIX 41 41 TRP B 261 ASN B 263 5 3 HELIX 42 42 ILE B 264 VAL B 269 1 6 HELIX 43 43 VAL B 279 GLY B 287 1 9 HELIX 44 44 ASN B 289 LEU B 304 1 16 HELIX 45 45 PRO B 310 SER B 317 1 8 HELIX 46 46 THR B 352 LYS B 373 1 22 HELIX 47 47 PRO B 376 ARG B 380 5 5 HELIX 48 48 ASN B 384 THR B 401 1 18 HELIX 49 49 THR B 401 ILE B 408 1 8 HELIX 50 50 ASP B 417 ILE B 433 1 17 HELIX 51 51 PHE B 435 SER B 451 1 17 HELIX 52 52 PRO B 455 SER B 457 5 3 HELIX 53 53 ARG B 458 GLY B 472 1 15 HELIX 54 54 PHE B 484 LYS B 489 5 6 HELIX 55 55 TYR B 498 GLY B 520 1 23 HELIX 56 56 PRO B 524 CYS B 528 5 5 HELIX 57 57 SER B 533 GLY B 547 1 15 HELIX 58 58 PRO B 551 GLY B 561 1 11 HELIX 59 59 ALA B 567 ASN B 588 1 22 SHEET 1 AA 2 ILE A 248 PRO A 249 0 SHEET 2 AA 2 ILE A 473 CYS A 474 1 N CYS A 474 O ILE A 248 SHEET 1 AB 2 SER A 333 ASP A 336 0 SHEET 2 AB 2 PHE A 343 LYS A 346 -1 O ARG A 344 N TRP A 335 SHEET 1 BA 2 VAL B 127 CYS B 128 0 SHEET 2 BA 2 CYS B 136 TRP B 137 -1 O TRP B 137 N VAL B 127 SHEET 1 BB 2 ILE B 248 PRO B 249 0 SHEET 2 BB 2 ILE B 473 CYS B 474 1 N CYS B 474 O ILE B 248 SHEET 1 BC 2 SER B 333 ASP B 336 0 SHEET 2 BC 2 PHE B 343 LYS B 346 -1 O ARG B 344 N TRP B 335 SSBOND 1 CYS A 128 CYS A 136 1555 1555 2.04 SSBOND 2 CYS A 330 CYS A 348 1555 1555 2.05 SSBOND 3 CYS A 516 CYS A 528 1555 1555 2.03 SSBOND 4 CYS B 128 CYS B 136 1555 1555 2.04 SSBOND 5 CYS B 330 CYS B 348 1555 1555 2.05 SSBOND 6 CYS B 516 CYS B 528 1555 1555 2.03 LINK ND2 ASN A 45 C1 NAG D 1 1555 1555 1.44 LINK ND2 ASN A 416 C1 NAG E 1 1555 1555 1.45 LINK ND2 ASN A 480 C1 NAG C 1 1555 1555 1.46 LINK ND2 ASN B 45 C1 NAG G 1 1555 1555 1.46 LINK ND2 ASN B 416 C1 NAG H 1 1555 1555 1.45 LINK ND2 ASN B 480 C1 NAG F 1 1555 1555 1.45 LINK O6 NAG C 1 C1 FUC C 2 1555 1555 1.44 LINK O4 NAG D 1 C1 NAG D 2 1555 1555 1.44 LINK O4 NAG E 1 C1 NAG E 2 1555 1555 1.44 LINK O4 NAG E 2 C1 BMA E 3 1555 1555 1.44 LINK O6 NAG F 1 C1 FUC F 2 1555 1555 1.44 LINK O4 NAG G 1 C1 NAG G 2 1555 1555 1.44 LINK O4 NAG H 1 C1 NAG H 2 1555 1555 1.44 LINK O4 NAG H 2 C1 BMA H 3 1555 1555 1.45 LINK NE2 HIS A 361 ZN ZN A 701 1555 1555 2.22 LINK NE2 HIS A 365 ZN ZN A 701 1555 1555 2.20 LINK OE1 GLU A 389 ZN ZN A 701 1555 1555 1.92 LINK ZN ZN A 701 OAG K26 A1001 1555 1555 2.53 LINK ZN ZN A 701 OAK K26 A1001 1555 1555 2.13 LINK NE2 HIS B 361 ZN ZN B 701 1555 1555 2.40 LINK NE2 HIS B 365 ZN ZN B 701 1555 1555 2.12 LINK OE1 GLU B 389 ZN ZN B 701 1555 1555 2.08 LINK ZN ZN B 701 PBK K26 B1001 1555 1555 2.57 LINK ZN ZN B 701 OAK K26 B1001 1555 1555 2.00 LINK ZN ZN B 701 OAG K26 B1001 1555 1555 2.34 CISPEP 1 ASP A 140 PRO A 141 0 1.83 CISPEP 2 TYR A 607 PRO A 608 0 -4.94 CISPEP 3 ASP B 140 PRO B 141 0 1.21 CISPEP 4 TYR B 607 PRO B 608 0 -2.72 CRYST1 73.005 77.320 82.070 88.69 64.53 75.29 P 1 2 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.013698 -0.003596 -0.006914 0.00000 SCALE2 0.000000 0.013372 0.001329 0.00000 SCALE3 0.000000 0.000000 0.013563 0.00000